Horizon Pharma (HZNP) Posts Q2 Loss of 62c/Share, Narrower than Views
Tweet Send to a FriendGet Alerts HZNP Hot Sheet
Trade HZNP Now!
Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of ($0.62), $0.04 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $4.44 million.
For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
- Mentor Graphics Corp (MENT) Tops Q1 EPS by 5c; Guides Q2, FY14
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
